HLA
KALA icon

Hamilton Lane Advisors’s KALA BIO KALA Stock Holding History

Hamilton Lane Advisors’s Portfolio KALA Stock Details KALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-14
Closed -$133K – 53
2019
Q3 		$133K Hold
14
– – 0.06% 49
2019
Q2 		$223K Hold
14
– – 0.11% 43
2019
Q1 		$289K Sell
14
-11
-44% -$195K 0.15% 47
2018
Q4 		$311K Hold
25
– – 0.27% 41
2018
Q3 		$1K Buy
+25
New +$762K 0.41% 32

Other funds holding KALA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Hamilton Lane Advisors's KALA Position: Q4 2019 in Review

Hamilton Lane Advisors sold out of KALA BIO (KALA) in Q4 2019, closing a stake of 14 shares — an estimated $133K sold.

Hamilton Lane Advisors first reported a position in KALA in Q3 2018 and held it in 5 quarters. The position peaked at $311K in Q4 2018. 63 funds tracked by Wall St. Rank hold KALA as of Q4 2019.

  • Hamilton Lane Advisors reported no remaining KALA BIO position as of Q4 2019 after selling out during the quarter.
  • Hamilton Lane Advisors sold 14 KALA BIO shares in Q4 2019, an estimated $133K.
  • Hamilton Lane Advisors first reported a position in KALA BIO in Q3 2018 and held it in 5 quarters.
  • Hamilton Lane Advisors's KALA BIO position peaked at $311K in Q4 2018.
  • 63 funds tracked by Wall St. Rank held KALA BIO as of Q4 2019.

Based on Hamilton Lane Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.